Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Stock Investors

290 Followers
Based on 746,050 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TRVI
On average, investors allocate 1.68% of their portfolios to TRVI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,050 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TRVI

2.1%
Last 7
Days
2.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TRVI, out of 746,050 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TRVI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,161 investors who made their portfolios public
The table shows changes in TRVI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TRVI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.54%
-1.95%
-5.06%
190.44M
Healthcare
ChargePoint Holdings
4.22%
-1.40%
-2.54%
935.67M
Consumer Cyclical
Assertio Therapeutics
2.88%
-1.85%
-4.72%
157.91M
Healthcare
DraftKings
5.81%
-0.93%
-1.56%
33.23B
Consumer Cyclical
Devon Energy
5.27%
+0.90%
+4.63%
29.17B
Energy
Merck & Company
3.91%
+0.78%
+3.63%
323.59B
Healthcare
GE Aerospace
5.18%
-0.09%
+1.10%
174.05B
Industrials
Marathon Digital Holdings
5.57%
-0.91%
-0.23%
5.67B
Financial
Riot Platforms
4.92%
-0.48%
+0.48%
2.83B
Financial
Raytheon Technologies
3.99%
-0.96%
-0.64%
134.65B
Industrials
Based on the activity of 746,050 active portfolios
Open your Smart Portfolio

TRVI Investor Analysis

TRVI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of TRVI holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
TRVI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.3%
of TRVI holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
TRVI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.6%
of TRVI holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of TRVI stock investors
See who invests in TRVI according to age group and performance.

FAQ

How many retail Investors hold TRVI?
<0.1% of TipRanks' retail investors hold TRVI in their portfolios.
    What is TRVI Investor Sentiment?
    TRVI’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TRVI in the last 7 days?
      ▼ 2.1% of TipRanks' retail investors changed their holding of TRVI in the last 7 days.
        What percentage of retail investors changed their holding of TRVI in the last 30 days?
        ▼ 2.5% of TipRanks' retail investors changed their holding of TRVI in the last 30 days.
          What is the average age of retail investors who hold TRVI?
          The average age of TRVI Holders is between 35–55.
            What other stocks have TRVI investors also bought?
            TRVI Investors also bought CHRS, CHPT, ASRT, DKNG, DVN, MRK, GE, MARA, RIOT, RTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BSXBoston Scientific
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              INSMInsmed
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis